We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

- Parkinson's Disease
- Completed

Study Title: Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

Teva Identifier: TVP - 1012/135 Open Label

ClinicalTrials.gov Identifier: NCT00203164

Study Status: Completed

Trial Condition(s): Parkinson's Disease

Interventions: Drug: rasagiline mesylate

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

neurology icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 30 Years and older

Trial Duration: 05/01/2002 - 09/01/2006

Phase: Phase 3

Study Type

Interventional